Toll-Like Receptor program will be used to develop candidates in oncology and allergy. VentiRx Pharmaceuticals obtained exclusive, worldwide rights to Array BioPharma’s Toll-like receptor (TLR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results